deferasirox has been researched along with Liver Failure, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guerriero, R; Guilliams, KP; Hulbert, ML; Shinawi, MS; Stoll, JM; Towerman, AS; Willis, DN | 1 |
| Arnon, R; Chu, J; Ramaswami, A; Rosen, DJ; Wistinghausen, B | 1 |
| Halligan, K; Hickling, M; Menaker, N; Nepo, A; Paige, J; Shur, N; Weintraub, L | 1 |
3 other study(ies) available for deferasirox and Liver Failure, Acute
| Article | Year |
|---|---|
Hyperammonemia and acute liver failure associated with deferasirox in two adolescents with sickle cell disease.
Topics: Adolescent; Anemia, Sickle Cell; Benzoates; Deferasirox; Humans; Hyperammonemia; Iron Chelating Agents; Liver Failure, Acute | 2023 |
Fulminant Liver Failure in a Child With β-Thalassemia on Deferasirox: A Case Report.
Topics: Benzoates; beta-Thalassemia; Child, Preschool; Deferasirox; Fanconi Syndrome; Female; Humans; Liver Failure, Acute; Triazoles | 2017 |
Acute Liver Failure During Deferasirox Chelation: A Toxicity Worth Considering.
Topics: Anemia, Sickle Cell; Benzoates; Bilirubin; Blood Transfusion; Child; Deferasirox; Ferritins; Humans; Iron Chelating Agents; Liver Failure, Acute; Male; Transaminases; Triazoles | 2017 |